Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

434 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

NCT05365581

Conditions
Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +5 more
Locations
  • University of California Irvine Medical Center Orange, California, United States
  • UCLA Dept of Medicine - Hematology/Oncology, Santa Monica Santa Monica, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View all 46 locations
View Trial Details
Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

NCT06592924

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 395 locations
View Trial Details
Recruiting

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

NCT06844383

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Masonic Cancer Center Minneapolis, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

NCT04379596

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • Research Site Santa Monica, California, United States
  • Research Site Westwood, Kansas, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Boston, Massachusetts, United States
View all 100 locations
View Trial Details
Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

NCT05873686

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +28 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

NCT06902545

Conditions
Adenocarcinoma, Carcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, +6 more
Locations
  • KR82010 Goyang-si, Gyeonggi-do, South Korea
  • KR82008 Suwon, Gyeonggi-do, South Korea
  • KR82009 Suwon, Gyeonggi-do, South Korea
  • KR82006 Yangsan, Gyeongsangnam-do, South Korea
View all 13 locations
View Trial Details

Related conditions